SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Multiple Sclerosis
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Liuzzi, G. M.
Right arrow Articles by Riccio, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liuzzi, G. M.
Right arrow Articles by Riccio, P.
Right arrowPubmed/NCBI databases
*Substance via MeSH
Medline Plus Health Information
*Multiple Sclerosis
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Interferon-beta inhibits the expression of metalloproteinases in rat glial cell cultures: implications for multiple sclerosis pathogenesis and treatment

Grazia Maria Liuzzi

Department of Biochemistry and Molecular Biology, University of Bari, 70126 Bari, m.g.liuzzi{at}biologia.uniba.it

Tiziana Latronico

Department of Biochemistry and Molecular Biology, University of Bari, 70126 Bari

Anna Fasano

Department of Biochemistry and Molecular Biology, University of Bari, 70126 Bari

Giulia Carlone

Department of Biochemistry and Molecular Biology, University of Bari, 70126 Bari

Paolo Riccio

Department of Biology D.B.A.F., University of Basilicata, 85100 Potenza, Italy

Matrix metalloproteinases (MMPs) have been identified as mediators of brain injury in multiple sclerosis (MS) and it has recently been reported that treatment of MS patients with interferon-beta (IFN-b) reduces MMP-9 serum levels and in vitro release from monocytes. We investigated whether IFN-b is able to modulate the expression of MMPs in glial cell cultures. Rat microglial and astrocyte cultures were treated with different doses of IFN-b, then activated by exposure to LPS. In another set of experiments cells were simultaneously activated with LPS and treated with IFN-b. C ulture supernatants collected from astrocytes and microglia were subjected to zymography for the assessment of MMP-2 and MMP-9. Increased amounts of MMP-9 and MMP-2 were observed in supernatants from LPS-treated astrocytes in comparison with supernatants from nontreated control cells. MMP-9 also increased in LPS-treated microglia. The treatment of astrocytes and microglia with IFN-b inhibited dose-dependently the expression of both MMP-2 and MMP-9 in LPS-treated astrocytes and of MMP-9 in LPS-treated microglia. These results demonstrate a modulating effect of IFN-b on the release of MMPs from C NS cells. This effect represents an additional mechanism by which IFN-b may decrease the development of new C NS lesions in the course of MS.

Key Words: astrocytes • blood-brain barrier • demyelination • IFN-ß • microglia • MMPs • multiple sclerosis

Multiple Sclerosis, Vol. 10, No. 3, 290-297 (2004)
DOI: 10.1191/1352458504ms1016oa


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Mult SclerHome page
Y Benesova, A Vasku, H Novotna, J Litzman, P Stourac, M Beranek, Z Kadanka, and J Bednarik
Matrix metalloproteinase-9 and matrix metalloproteinase-2 as biomarkers of various courses in multiple sclerosis
Multiple Sclerosis, March 1, 2009; 15(3): 316 - 322.
[Abstract] [PDF]


Home page
StrokeHome page
G. J. del Zoppo, R. Milner, T. Mabuchi, S. Hung, X. Wang, G. I. Berg, and J. A. Koziol
Microglial Activation and Matrix Protease Generation During Focal Cerebral Ischemia
Stroke, February 1, 2007; 38(2): 646 - 651.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
I. Teige, Y. Liu, and S. Issazadeh-Navikas
IFN-beta Inhibits T Cell Activation Capacity of Central Nervous System APCs
J. Immunol., September 15, 2006; 177(6): 3542 - 3553.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A.D. Hauer, C. Uyttenhove, P. de Vos, V. Stroobant, J.C. Renauld, T.J.C. van Berkel, J. van Snick, and J. Kuiper
Blockade of Interleukin-12 Function by Protein Vaccination Attenuates Atherosclerosis
Circulation, August 16, 2005; 112(7): 1054 - 1062.
[Abstract] [Full Text] [PDF]



Advertisement